MedTrace Logo

Evaluation and Implementation of New Biomarkers and Algorithms for Diagnosis of Ovarian Cysts/Tumors in the Pelvis

NCT03193671 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 684

Last updated 2017-08-29

No results posted yet for this study

Summary

This study evaluates the biomarkers CA125 and HE4 and the algorithms RMI and ROMA on a normal population in the western region of Sweden. The aim is to improve diagnosis of ovarian cancer.

If the investigators observe a clear improvement in the early diagnosis of EOC, the investigators aim to implement the best strategy for all patients with suspected pelvic tumor mass in the western region of Sweden.

Conditions

  • Ovarian Neoplasms
  • Diagnoses Disease
  • Biomarkers
  • Algorithms

Interventions

DIAGNOSTIC_TEST

Diagnosis

Improving diagnosis

Sponsors & Collaborators

  • Göteborg University

    lead OTHER

Eligibility

Min Age
18 Years
Sex
FEMALE
Healthy Volunteers
No

Timeline & Regulatory

Start
2013-09-01
Primary Completion
2016-02-29
Completion
2016-02-29

Countries

  • Sweden

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03193671 on ClinicalTrials.gov